Albany, NY -- (SBWIRE) -- 11/28/2014 -- Since the last two decades, preimplantation genetic diagnosis (PGD) has been used to detect chromosomal aneuploidy in low prognosis patients who undergo in-vitro fertilization (IVF). PGD is now being used to detect a broader range of indications due to advancements in the medical technology. These indications include chromosomal aberrations, genetic abnormalities, gender selection, HLA typing, X-linked diseases and single gene diseases. Demand for PGD is continuously increasing in patients who undergo IVF in the hope that it would improve the probability of live birth and reduce the chances of disabilities and genetic disorders in the offspring.

View Full Report at http://www.marketresearchreports.biz/analysis/138703

This report provides in-depth analysis of the preimplantation genetic diagnosis market and its test types across various regions. Stakeholders in the report include diagnostic laboratories that provide PGD services, companies involved in the production of diagnosis kits and sequencers for PGD, and prospective market players planning to enter the market. The report comprises executive summary, which offers a market snapshot that covers the overall information about various types of tests in the PGD market.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/138703

The market overview section explains market dynamics such as drivers, restraints and opportunities that influence the current and future status of the preimplantation genetic diagnosis market. Impact factors such as market attractiveness analysis and regulatory framework of PGD in various countries has been included in this section in order to provide a thorough analysis of the overall competitive scenario of the global preimplantation genetic diagnosis market. The report covers competitive analysis, which includes heat map analysis by key market players. Through heat map analysis, the stakeholder would be able to identify the presence of players across various segments of the market. All these factors would help market players gain a thorough understanding of the overall competitive scenario. The market players can then decide upon the business strategies and plans to be implemented in order to strengthen their position in the global market.

Explore All Latest Published Reports By Transparency Market Research at http://www.marketresearchreports.biz/publisher/14

The global preimplantation genetic diagnosis market has been differentiated based on the types of tests and geographies. Based on the types of tests, the global preimplantation genetic diagnosis market has been segmented into six categories: PGD for chromosomal aberrations, aneuploidy screening, X-linked diseases, single gene disorder, HLA typing and gender selection. A detailed market analysis of the segments mentioned above has been provided at the global level in this study. The market analysis is based on market size and forecast in terms of USD million for the period 2013 to 2020 along with the compounded annual growth rate (CAGR %) for the period 2014 to 2020, considering 2013 as the base year.

Geographically, the global preimplantation genetic diagnosis market has been categorized into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW). This section further provides market size and forecast for various types of PFD tests in each region. The market size and forecast of the regional markets is provided for the period 2012 to 2020. CAGR (%) for each region is also estimated for the period 2014 to 2020, considering 2013 as the base year. The report also includes strategic recommendations, which would help market players sustain and grow in the highly competitive market. These recommendations would also help new entrants establish a strong position in the global preimplantation genetic diagnosis market.

Company profiles section comprises key information such as company overview, financial overview, product portfolio, business strategies and recent developments about major players operating in the preimplantation genetic diagnosis market. Key players profiled in the report include Genesis Genetics, Genea Ltd., Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer, Inc., Quest Diagnostics, Inc., Reprogenetics LLC and Reproductive Genetics Institute.

The global preimplantation genetic diagnosis market is segmented into the following categories:

Preimplantation Genetic Diagnosis Market, by Test Type

PGD for Chromosomal Aberrations
PGD for Aneuploidy Screening
PGD for Gender Selection
PGD for Single Gene Disorder
PDG for HLA Typing
PGD for X-linked Diseases

Preimplantation Genetic Diagnosis Market, by Geography

North America
PGD for Chromosomal Aberrations
PGD for Aneuploidy Screening
PGD for Gender Selection
PGD for Single Gene Disorder
PDG for HLA Typing
PGD for X-linked Diseases
Europe
PGD for Chromosomal Aberration
PGD for Aneuploidy Screening
PGD for Gender Selection
PGD for Single Gene Disorder
PDG for HLA Typing
PGD for X-linked Diseases
Asia Pacific
PGD for Chromosomal Aberrations
PGD for Aneuploidy Screening
PGD for Gender Selection
PGD for Single Gene Disorder
PDG for HLA Typing
PGD for X-linked Diseases
Rest of the World (RoW)
PGD for Chromosomal Aberrations
PGD for Aneuploidy Screenin
PGD for Gender Selection
PGD for Single Gene Disorder
PDG for HLA Typing
PGD for X-linked Diseases

Related Reports

Market Snapshot: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Asia-Pacific

View Full Report at http://www.marketresearchreports.biz/analysis/232569

BI Research’s report, “Market Snapshot: Aesthetic Lasers and Energy Devices Market 2006 to 2020 Asia-Pacific” provides quantitative analysis of the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. The analysis includes market size data by revenue and volume over the 2006 2020 period for the following countries: China, Japan, South Korea, Australia and India. It uses data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/232569

Scope

* Information on market size for the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices.
* Annualized sales data by revenue for the 2006 2020 period and company share data by revenue for 2013
* Annualized sales data by volume for the 2006 2020 period
* Coverage of key geographies: China, Japan, South Korea, Australia and India

MediPoint: Coronary Stents - Global Analysis and Market Forecasts

View Full Report at http://www.marketresearchreports.biz/analysis/233280

The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/233280

Among the different types of stents, drug-eluting stents (DES) dominate the market and are considered to be the gold standard of treatment for coronary artery disease. The rising prevalence of disease and associated risk factors, especially in the emerging markets, and improved outcomes with stenting are expected to drive the adoption of coronary stents in the future. Emerging technologies such as the new generation of DES and bioabsorbable stents (BAS) represent the future of the coronary stent market. BAS offer several benefits, including no metal left behind, enhanced vessel healing, feasibility of future interventions and potentially reducing the need for prolonged dual antiplatelet therapy. With improvements in the design of BAS, they have the potential to become the standard of treatment for coronary artery disease in the future.

About MarketResearchReports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Blog at http://2014marketresearch.blogspot.com/